Navigation

Ovarian cancer

Note: The information on cancer types on the ACRF website is not designed to provide medical or professional advice and is for information only. If you have any health problems or questions please consult your doctor. All statistics have been sourced from the Australian Institute of Health and Welfare.

Ovarian Cancer Statistics:

  • In 2010, ovarian cancer was the most common cause of gynaecological cancer death in Australia, with 912 deaths.
  • In 2009, ovarian cancer was the second most commonly diagnosed gynaecological cancer in Australia.
  • In 2009, the risk of developing ovarian cancer before the age of 85 was one in 75.
  • The five-year relative survival rate for ovarian cancer is 43.3 per cent.

More cancer stats

Ovarian Cancer Overview

Ovarian cancer is a disease where some of the cells in one or both ovaries (the two small almond shaped organs that are part of the female reproductive system) start to grow abnormally and develop into cancer.

The ovaries are made up of germ cells, stromal cells and epithelial cells and each of these are susceptible to different cancers. There are four main types of ovarian cancer, these are:

  • Epithelial ovarian cancer is the most common and develops in the epithelium, which is the surface of the ovary. At least 15% of epithelial ovarian cancers are thought to be the result of inheriting a faulty gene from either your mother or father’s side of the family. Epithelial ovarian cancer can be found in women at any age but is most common in women over 50 years of age.
  • Borderline ovarian tumours are a group of epithelial tumours that don’t spread as quickly as other forms of ovarian cancer.
  • Germ cell ovarian cancer begins in the cells that mature into eggs. These tumours account for about 5% of ovarian cancers and usually affect women under 30 years.
  • Sex-cord stromal cell ovarian cancer begins in the ovary cells that release female hormones. These tumours account for about 5% of ovarian cancers and can affect women of any age.

Both germ cell and sex-cord stromal cell ovarian cancers respond well to treatment and have a higher survival rate. If only one ovary is affected by either of these two cancers it may be possible for younger women to have children after treatment.

A family history of ovarian cancer is the strongest risk factor for developing the disease. Inheriting a faulty BRCA1 or BRCA2 gene is involved in most cases of hereditary ovarian cancer.

Women who inherit a mutation in the BRCA1 gene have approximately a 40% lifetime risk of developing ovarian cancer, while women who inherit a faulty BRCA2 gene have approximately 10-15% risk of developing ovarian cancer.

Sometimes ovarian cancer cells travel in the bloodstream or lymphatic system to other parts of the pelvis, or to areas outside the pelvis such as the lungs or liver. This is called advanced ovarian cancer (or metastatic ovarian cancer).

Ovarian Cancer Symptoms

It is important to note that the symptoms of ovarian cancer are often vague and can be similar to the symptoms of many other conditions that can be part of everyday life. If any of these symptoms are experienced in an unusual way or persist, it is important to discuss them with your GP.

  • Abdominal bloating/feeling full
  • Abdominal or back pain
  • Appetite loss or feeling full quickly
  • Changes in toilet habits
  • Unexplained weight loss or weight gain
  • Indigestion or heartburn
  • Fatigue

Ovarian Cancer Treatment

Treatment for ovarian cancer usually involves a combination of surgery and chemotherapy. Less often, treatment may include radiotherapy. The type of treatment women receive depends on the type and stage of their ovarian cancer and their general health.

The first treatment stage of ovarian cancer is generally an operation called a laparotomy. This operation is also the main way that a diagnosis of ovarian cancer is confirmed.

A vertical cut is made to look inside the abdomen and a small section of the ovarian tumour is removed for examination (a biopsy). This is called a frozen section. If the frozen section confirms that the tumour is cancer, the operation will continue.

If cancer is confirmed and the disease appears confined to the ovary, a ‘staging laparotomy’ will take place, involving biopsies taken from the omentum, peritoncum and lymph nodes to see if and where the cancer has spread.

Depending on the stage of the cancer the operation can involve removal of both ovaries, fallopian tubes, the uterus, the omentum (the fat pad around the organs in your abdomen), the appendix and some of the lymph glands in the area. Sometimes it may be necessary to remove some of the bowel.

Most women with ovarian cancer will require chemotherapy. Chemotherapy treatment is given under the guidance of a medical oncologist.

Radiotherapy is rarely used as a primary treatment for ovarian cancer, but rather as part of overall treatment.

Everyone’s situation and ovarian cancer is different. A treatment plan for one woman may not be suitable for another woman. Deciding on the most appropriate treatment(s) means weighing up the possible benefits and side effects of each treatment. Treatment is best managed by a gynaecological oncologist.

LATEST Ovarian Cancer

Chris celebrates her 50th birthday while supporting cancer research

“Turning 50 was a milestone in my life. My only sadness, as that milestone approached, was that I wouldn’t get to share…

Tracking ovarian cancers' evolution to change approaches to treatment

We often think of evolution as a positive thing, associating it with progress, growth and development. But because evolution exists in all…

New screening technique developed to detect ‘silent’ ovarian cancers early.

Ovarian cancer is often referred to as a ‘silent killer’, with around one hundred thousand women succumbing to the disease globally each…

Cancer Research Discoveries | ACRF

Cancer immunity enhanced by natural killer cells

A team of researchers from Australia and France have uncovered new insights into how to prolong the lifespan of the body’s disease-fighting…

New ACT drug discovery platform

Today, Australian National University (ANU), the ACT Minister for Health and Australian Cancer Research Foundation (ACRF) will launch a new robotic system…

Aggressive prostate cancer linked to faulty BRCA2 gene

New research has revealed why men with a family history of prostate cancer, and who also carry the BRCA2 gene fault, have…

UPCOMING EVENTS